Group 1 - The Shanghai Stock Exchange held a special meeting to promote the "1+6" policy for the Sci-Tech Innovation Board, aiming to enhance the coordination between investment and financing in the capital market [1] - Over 100 representatives from more than 20 market institutions, including public funds, securities companies, and insurance asset management, attended the meeting, showing strong support for the series of reform measures [1] - The Sci-Tech Innovation Board has become the segment with the highest proportion of index investment in A-shares, with the free-floating market value proportion reaching 8.3% [1] Group 2 - The "1+6" policy framework is expected to provide new opportunities for index investment in the Sci-Tech Innovation Board, injecting lasting momentum into the market's healthy and stable development [2] - The Shanghai Stock Exchange plans to enhance communication with market participants and implement relevant policy deployments to support innovation-driven development [2] - The number of Sci-Tech Innovation Board ETFs has nearly doubled since the release of the "Eight Measures," with a total of 85 ETFs listed and a total scale exceeding 250 billion yuan, reflecting a growth of over 60% [1][2]

6月11日，上交所组织召开"科创板八条"一周年投资端座谈会，基金管理人以及保险、券商、银行、银 行理财子公司等机构代表参加。座谈会上，与会机构就科创板指数化投资、ETF高质量发展生态建设等 话题进行探讨。 在与会机构代表看来，当前境内指数化投资趋势正加速形成，科创板ETF日益成为投资者参与科创板投 资的重要渠道，持续吸引资金流入"硬科技"企业。 证券时报记者 张淑贤 与会机构代表表示，科创板ETF为投资者一键布局科创板提供了便利，在助力保险、银行等中长期资金 入市方面也发挥了重要作用。据悉，目前布局科创板ETF的基金公司达27家，较"科创板八条"发布前增 加了13家。 座谈会上，机构代表建议优化科创板ETF相关配套机制。对此，上交所相关负责人表示，正加快推动将 科创板ETF纳入基金通平台转让，研究优化做市商机制、盘后固定价格交易机制，积极引导更多社会资 金流向"新质生产力"等国家重点支持领域，满足广大投资者资产配置需求。 与会机构代表同时表示，要充分发挥投资端改革先锋作用，以实际行动积极投身科创板市场建设，共同 营造科创板投资良好生态。 上交所相关负责人表示，上交所将继续推动科创板改革走深走实，持续加强与市场 ...

□本报记者张凌之 业内呼吁已久的ETF纳入基金投顾配置范围迎来关键破局。 近日，证监会明确表态将科创板ETF纳入基金投顾配置范围，旨在丰富投资工具、引导中长期资金流向 新质生产力领域。为迎接这一变革，各家基金投顾机构正在紧锣密鼓地改造投研平台与交易系统，有些 机构已经做好准备，投顾策略可以及时纳入科创板ETF。 业内人士表示，科创板ETF纳入基金投顾配置范围为后续更多ETF纳入基金投顾领域奠定了基础，推动 行业向更高效、多元的方向发展，也将对投顾行业的商业模式和竞争格局产生深远影响。 科创板ETF纳入投顾配置范围 近日，证监会发布《关于在科创板设置科创成长层增强制度包容性适应性的意见》。《意见》提出，丰 富科创板指数及ETF品类，将科创板ETF纳入基金投顾配置范围，促进更多中长期资金向发展新质生产 力集聚。 "在资产配置中，科创板上市企业具有鲜明的特征：在行业方面，科创板集中在电子、医药、机械等方 向，覆盖集成电路设计、专用软件、生物制药等高科技领域，符合新质生产力的发展要求；在市值方 面，科创板聚集了一批市值偏小的初创企业和一批优质的专精特新'小巨人'企业，对于中小市值标的有 较好的覆盖度；在公司层面，科创 ...

Group 1: Market Performance - A-shares experienced a significant rebound on June 25, with the Shanghai Composite Index reaching a new high for the year, and the ChiNext Index rising over 3% [1][3] - The total market capitalization of A-shares reached 99.93 trillion yuan, marking a historical peak [1] - Over 3,900 stocks in the A-share market rose, with a trading volume of 1.64 trillion yuan on the same day [1][3] Group 2: Institutional Research and Preferences - In June, 836 listed companies received institutional research, with nearly 70% of these companies showing positive returns [2] - The electronics sector was the most favored by institutions, with 94 companies receiving research, particularly in PCB, AI applications, and semiconductor chips [2] - The pharmaceutical and biotech sectors also attracted significant institutional interest, especially in the CXO (contract research organization) segment [2] Group 3: Foreign Investment Sentiment - Global market risk appetite has improved, leading to a surge in Chinese assets, with foreign institutions expressing optimism about the Chinese stock market [3] - Key factors for this optimism include resilient macroeconomic conditions, improving corporate profits, and supportive incremental policies [3] - As of June 25, 21 companies had provided earnings forecasts for the first half of 2025, with 15 expecting positive net profit growth [3] Group 4: Cross-Border Business Development - Domestic securities firms are establishing cross-border business collaboration platforms and forming specialized teams for Hong Kong stock market expansion [4] - The Hong Kong Stock Exchange has introduced measures to facilitate A-share companies listing in Hong Kong, leading to a quicker review process [4] Group 5: Virtual Asset Trading - Guotai Junan International received approval to upgrade its trading license to include virtual asset trading, resulting in a significant stock price increase [5] - The approval has led to a surge in the Hong Kong Chinese brokerage index, with other firms also actively applying for similar licenses [5] Group 6: Short Drama Industry Growth - The short drama industry has seen explosive growth, with the interactive game index for short dramas rising 5.72% this year, outperforming the broader market [8] - Several listed companies in this sector have experienced stock price increases exceeding 40% [8] - Major internet companies are intensifying competition in the short drama space, with notable initiatives from Tencent, Xiaohongshu, and Bilibili [8]

丰富科创板指数及ETF品类，将科创板ETF纳入基金投顾配置范围，研究推出更多科创板ETF期权和期 货期权…… 健全投资和融资相协调的市场功能是科创板改革的重要内容之一。在市场人士看来，通过丰富科创板 ETF品类和其他衍生品，可为投资者提供更多元的参与方式和更有效的风险管理手段，加快构建投融资 协调的市场生态。 丰富科创板指数及ETF品类 《关于在科创板设置科创成长层增强制度包容性适应性的意见》（以下简称《科创板意见》）提出，丰 富科创板指数及ETF品类，将科创板ETF纳入基金投顾配置范围。在市场人士看来，这是资本市场服务 新质生产力的又一重要举措——通过拓宽基金投顾工具池等，引导中长期资金流向新质生产力领域，同 时通过专业机构的组合管理提升资金使用效率。 "美国90%的投顾使用ETF构建组合。"盈米基金研究院高级研究员王誉蓉说，科创板ETF纳入基金投顾 范围将拓宽投顾策略边界，降低投资者成本，吸引长期资金入市，为后续更多ETF纳入基金投顾奠定基 础。 证监会近日表示，将支持在上海设立专门科技公司，建设新型资产管理服务平台，助力各类投资机构进 一步提升投资和风险管理能力。 更大力度培育壮大耐心资本 加快构建更有 ...

Group 1 - The core viewpoint emphasizes the need for cultivating patient capital to bridge the funding gap and cycle mismatch in the integration of technological and industrial innovation [1][2] - The China Securities Regulatory Commission (CSRC) chairman highlighted the importance of long-term capital in supporting the sustainable growth of technology enterprises [1][4] - Private equity funds play a crucial role in nurturing patient capital, as they align with the growth patterns of technology innovation and cover the financing needs throughout the lifecycle of tech companies [1][2] Group 2 - Recent data shows that private equity and venture capital funds have invested in 90% of companies listed on the Sci-Tech Innovation Board and over half of those on the Growth Enterprise Market [2] - As of April 2025, there are nearly 20,000 private fund managers managing over 140,000 funds with a total scale of 20 trillion yuan [2] - The CSRC plans to focus on enhancing the fundraising, investment, management, and exit processes of private equity funds to attract more long-term capital [2][3] Group 3 - The development of technology innovation indices can provide a safety net and value anchor for patient capital by accurately selecting technology assets with long-term growth potential [3] - The introduction of public funds with technology attributes can transform fragmented and short-term market funds into long-term capital supporting technological innovation [3] - Since the launch of the "Eight Measures for the Sci-Tech Innovation Board," multiple technology innovation indices have been released, significantly contributing to attracting incremental capital into the market [3][4] Group 4 - The continuous nurturing of patient capital is essential for the growth of technology and industrial innovation, with expectations for improved policy environments and diversified funding sources [4] - The capital market is anticipated to accelerate the cultivation of patient and long-term capital to support the growth of technology enterprises and the rise of emerging industries [4]

Group 1 - The core viewpoint of the article is that the recent regulatory changes by the China Securities Regulatory Commission (CSRC) are transforming the wealth management landscape in China, particularly by allowing direct investment in Sci-Tech Innovation Board ETFs through fund advisory services [1][2] - The number of Sci-Tech Innovation Board ETFs has increased from 4 to 94 since their inception in November 2020, with total assets growing from 20.97 billion to 266.48 billion, reflecting strong investor interest in participating in technology innovation [2][4] - The inclusion of Sci-Tech Innovation Board ETFs in fund advisory services is expected to enhance the flexibility of investment strategies, allowing for more tailored approaches to meet investor needs [2][3] Group 2 - The management fee for Sci-Tech Innovation Board ETFs is approximately 0.5% per year, which is lower than that of actively managed funds, typically over 1% per year, making them a cost-effective option for investors [3][4] - The long-term funding support from stable advisory funds is crucial for technology companies, especially given their high R&D investment, with total R&D expenditure projected to reach 168.86 billion in 2024, accounting for 11.89% of revenue [4][5] - Fund advisory institutions are rapidly adjusting their strategies to incorporate Sci-Tech Innovation Board ETFs, with firms like E Fund and Bosera already integrating these assets into their investment models [5][6] Group 3 - The article highlights the need for improved investor education regarding ETFs, as many investors currently view them only as tools rather than understanding their strategic value [7][8] - There is potential for more ETF categories, such as CSI 300 ETF and commodity ETFs, to be included in fund advisory services, indicating a shift towards a more diversified and professional wealth management approach [8] - The transformation initiated by the inclusion of Sci-Tech Innovation Board ETFs is pushing the wealth management industry in China towards a more specialized and diversified phase, balancing innovation with risk and short-term gains with long-term value [8]

Group 1 - The core viewpoint of the news is the introduction of the "Opinions on Setting Up a Growth Layer in the Sci-Tech Innovation Board" by the China Securities Regulatory Commission, which aims to enhance the market's investment and financing functions and promote the aggregation of medium- and long-term funds towards new productive forces [1] - The inclusion of Sci-Tech Innovation Board ETFs in the fund advisory configuration range is significant, as it is expected to broaden the investment scope of fund advisors and attract long-term quality funds to invest in the Sci-Tech Innovation Board [2] - The number of fund companies laying out Sci-Tech Innovation Board ETFs has reached 27, indicating a growing interest and recognition of these products in the market, with approximately 1.23 billion yuan attracted by the Sci-Tech Innovation Board 50 ETF from June 18 to June 24 [3] Group 2 - The introduction of more Sci-Tech Innovation Board ETF options and futures is seen as beneficial for investors to manage risks associated with short-term market fluctuations, thereby attracting more medium- and long-term funds [4] - The upcoming allowance for qualified foreign investors to participate in on-site ETF options trading starting from October 9, 2025, is expected to enhance the stability of foreign institutional investment behavior and promote long-term investment in A-shares [4] - The diversification of Sci-Tech Innovation Board-related ETFs and other derivatives is anticipated to provide investors with more participation methods and effective risk management tools, enhancing market attractiveness and liquidity [4]

Core Insights - The China Securities Regulatory Commission (CSRC) has included Sci-Tech Innovation Board (STAR Market) ETFs in the fund advisory configuration scope, enhancing the flexibility of advisory strategies and reducing investment costs [1][5] - This policy change is seen as a significant breakthrough, allowing advisory institutions to construct more flexible and diverse strategy combinations based on ETFs, leading to improved tracking accuracy and trading efficiency [1][5] Group 1: Policy Impact - The inclusion of STAR Market ETFs is expected to attract more medium to long-term capital towards developing new productive forces [1] - The management fee for STAR Market ETFs is as low as 0.15%, and transactions are exempt from stamp duty and transfer fees, significantly improving cost efficiency [5] - The move is anticipated to enhance the liquidity of the STAR Market, as advisory funds typically have longer investment horizons and rational decision-making characteristics [6] Group 2: Implementation Challenges - Advisory institutions need to address compatibility, trading mechanisms, and risk control issues to effectively implement this policy [5] - There are significant differences between the management of onshore public funds and ETFs, necessitating adaptations in trading systems and account management [5][6] - The introduction of STAR Market ETFs into advisory strategies presents new challenges in cash management and portfolio adjustment due to the real-time price fluctuations of ETFs [5][6] Group 3: Future Opportunities - The inclusion of STAR Market ETFs is expected to enrich the product matrix available for investment and refine investment granularity [6] - If the pilot for STAR Market ETFs is successful, thematic ETFs related to artificial intelligence and biomedicine may also be included in the advisory configuration scope [7] - The anticipated influx of advisory funds could improve the liquidity structure of the STAR Market and reduce market volatility, providing more stable funding support for innovative enterprises [6]

该研报认为，对于盈利预期有所下修的科技板块而言，其胜率的提升或许需要期待AI相关产业趋势再 次启动，类似年初Deepseek出现所带来的商业格局冲击。然而，这种趋势的启动具有一定随机性，因此 左侧介入时更应注重赔率而非胜率。 值得一提的是，天风证券研报也谈到，今年以来，南向资金积极流入，港股IPO与再融资规模明显提 升，都增加了对港元的需求，推升港元汇率至强方保证。5月初，金管局释放银行总结余，带动Hibor回 落，港美利差负向走扩，可观的套息收益吸引外资涌入，外汇储备在5月也出现明显提升。（闻辉） 上述研报指出，从近期资金流向看，近一周南向资金流入金融业与医疗保健业，流出资讯科技业。市场 动态方面，科创板ETF被纳入投顾范畴，促进更多中长期资金向新质生产力领域聚集。 天风证券分析指出，自4月初以来，恒生指数虽已实现较为可观的涨幅，但板块热度分化明显。港股银 行板块拥挤度自3月起逐渐提升，但上升斜率较缓，仍低于去年平均水平，可认为市场情绪尚未过热。 恒生科技与港股创新药的拥挤度指标出现分化，前者回落至去年平均水平，后者则不断刷新近年高位。 新消费板块中，以泡泡玛特、老铺黄金、蜜雪集团为代表的成分股，其拥挤度中 ...